Japanese scientists develop enhanced vitamin K for neuron regeneration

Researchers in Japan have created new vitamin K compounds that are three times more effective than natural forms at turning stem cells into neurons. The work, published in 2025, targets diseases that destroy brain cells such as Alzheimer’s and Parkinson’s.

Associate Professor Yoshihisa Hirota and Professor Yoshitomo Suhara led the team at Shibaura Institute of Technology. They combined vitamin K with elements of vitamin A to produce 12 hybrid molecules. One compound, called Novel VK, stood out in tests on mouse neural progenitor cells for its strong ability to promote neuronal growth.

Labaran da ke da alaƙa

Microscopic view of enhanced natural killer cells attacking cancer cells due to a drug developed by McGill researchers.
Hoton da AI ya samar

McGill researchers use reversible drug approach to boost natural killer cells against hard-to-treat cancers

An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya

Researchers at McGill University report a drug-based method to temporarily enhance natural killer (NK) cells—an immune cell type—by inhibiting two proteins, improving the cells’ ability to attack several aggressive cancers in preclinical experiments.

Researchers at the University of Cambridge have developed miniature lab-grown models of the human brain and spinal cord that show damaged nerve fibers can regain the ability to regrow under certain conditions.

An Ruwaito ta hanyar AI

A widely studied anti-aging treatment triggered significant brain damage in mice, according to new research from the University of Connecticut. The drug combination dasatinib plus quercetin caused myelin loss and changes resembling those seen in multiple sclerosis. The findings raise questions about its use in longevity studies and off-label therapies.

Researchers at the University of Hong Kong have developed a world-first nasal spray that delivers neurotherapeutic powder directly to the brain as first aid for ischemic stroke patients. The treatment, named NanoPowder, is designed to reduce brain damage by more than 80 per cent and improve stroke survival rates. Clinical trials are expected by 2030.

An Ruwaito ta hanyar AI An Binciki Gaskiya

Northwestern University researchers report they have printed flexible “artificial neurons” that generate realistic electrical spike patterns and can trigger responses in living mouse brain tissue. The team says the work, published April 15 in Nature Nanotechnology, could help advance brain-machine interfaces and more energy-efficient, brain-inspired computing.

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi